Week in Review
The federal government relaxes regulatory burdens amid the coronavirus pandemic, states struggle to amend election rules, and more…
Proposal to Import Prescription Drugs Faces Criticism
Critics of a proposed rule to import drugs from Canada cite safety concerns and other potential problems.
The Pandemic and Industry Opportunism
EPA fails to hold environmental polluters responsible during the COVID-19 crisis.
COVID-19, Domestic Violence, and Guns
Trapped at home with their abusers, victims must rely on programs whose long-term funding remains in doubt.
FDA Versus Our Own Stem Cells
The federal government seeks authority over stem cell treatments but risks thwarting medical advancement.
Moving Toward Comprehensibility in the Legal System
We need to extend and expand an overdue conversation about clarity in the U.S. legal system.
The Elusive Pursuit of Comprehensibility
Simplified communication may not fix incomprehensible disclosures.
Natural Gas is Key to Addressing Climate Change
Natural gas continues to play a vital role in reducing U.S. greenhouse gas emissions.
Unemployment and COVID-19
As the coronavirus pandemic hit the U.S. economy, over ten million Americans filed for unemployment insurance.
Week in Review
CMS issues temporary waivers to hospitals amid the coronavirus pandemic, the Trump Administration rolls back vehicle emissions standards, and more…
FDA Relaxes Rules on Ventilators for COVID-19
Responding to the coronavirus outbreak, a federal agency relaxes requirements on medical device manufacturers.